From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement

Prospects of chimeric antigen receptor T-Cell therapy in myelofibrosis: From immunopathogenesis to therapeutic strategies

Last Updated: Thursday, August 13, 2026

In a clinical review, researchers discuss potential CAR T-cell therapy targets in myelofibrosis. They highlight current translational challenges, such as on-target, off-tumor toxicity and impaired CAR-T persistence, and discuss emerging approaches.

Cancers
Advertisement
News & Literature Highlights
Advertisement
Advertisement